Enzalutamide and blocking androgen receptor in advanced prostate cance | RRU | Dove Medical Press
Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens Yusuke Ito, Marianne D Sadar Genome Sciences Centre, BC...
dovepress.com